Skip to main content
. 2019 Jun 17;87(11):943–951. doi: 10.1002/prot.25756

Table 6.

Small docking set of FDA approved type II inhibitors

Kinase PDB code Docked compounds
ABL1 2HYY, 3CS9, 3OXZ a Imatinib, nilotinib, ponatinib
KDR 3WZE, 4AG8 b Sorafenib, axitinib
a

All three ABL1 crystal structures are classified as A‐loop: “closed type 2,” P‐loop: “collapsed,” and αC‐helix: “αC‐in” (which is equivalent to HM 1).

b

All two KDR crystal structures are classified as A‐loop: “closed A‐under‐P,” P‐loop: “stretched,” and αC‐helix: “αC‐in” (which is equivalent to HM 12).